2Adachi T, Oda Y, Sakamoto A, et al. Prognostic factors in the so-ailed malignant mesenchymoma: a clinicopathological and immuno-histochemical analysis [J]. Oncol Rep, 2003,10 (4) :803 - 811.
2Stout AP. Mesenchymoma, the mixed tumor of mesenchymal derivatives[J]. Ann Surg, 1948, 127(2): 278-290.
3Newman PL, Fetcher CD. Malignant mesenchymoma: chinicopathologic analysis of a series with evidence of low-grade behavior[J]. Am J Surg Pathol, 1991, 15(7): 607-614.
4Mrad K, Sassi S, Smida M, et al. Osteosarcoma with rhabdomyosarcomatous component or so-called malignant mesenchymoma of bone[J]. Pathologica, 2004, 96(6): 475-478.
5De Padua M, Bhandari TP, Pingle J. Primary osteoliposarcoma of the bone[J]. Indian J Pathol Microbiol, 2009, 52(1): 80-82.
10Shibayama T, Ueoka H, Nishii IL, et al. Complementary roles of progastrin-releasing peptide ( ProGRP ) and neuron specific eno- lase(NSE) in diagnosis and prognosis of small-ceU lung cancer (SCLC). Lung Cancer,2001,32 (3) :61-62.
